RecruitingNCT05096923

UNC Childhood, Adolescent, and Young Adult Cancer Cohort


Sponsor

UNC Lineberger Comprehensive Cancer Center

Enrollment

500 participants

Start Date

Dec 17, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Purpose: This study aims to create a registry of childhood, adolescent, and young adult patients with cancer (\<40 years-old at cancer diagnosis), entitled the 'UNC Childhood, Adolescent, and Young Adult Cancer Cohort' (UNC-CAYACC). This resource will serve to support cancer outcomes research among pediatric and young adult cancer patients with a primary focus on enrolling patients treated as adolescents or young adults (AYAs, 15-39 years). Procedures: As appropriate for age, participants will complete physical and cognitive functional assessments; questionnaires to assess health-related quality of life and other patient-reported outcomes; will undergo body composition and anthropometric measurements; and will be asked to provide biospecimens for biobanking. Assessments will be collected (as possible) at diagnosis, during active treatment, following treatment completion, and annually in survivorship to assess outcomes throughout the treatment and survivorship trajectory. Sociodemographic and clinical information such as cancer treatment modalities and cumulative doses will be collected by medical record abstraction. Participants will be eligible to enroll at any time from diagnosis through survivorship. This registry will provide data to better understand the manifestations of accelerated aging and key contributing factors among children, adolescents, and young adults with cancer.


Eligibility

Min Age: 1 YearMax Age: 39 Years

Inclusion Criteria2

  • Patient ages 0-39 years at the time of cancer diagnosis (ages 1-39 years at enrollment) who are at any point in treatment and survivorship trajectory
  • English or Spanish speaking

Exclusion Criteria2

  • Unwilling to sign informed consent
  • Speak a language other than English or Spanish.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05096923


Related Trials